Artificial intelligence has been a hot topic for medtech recently, not least given the recent regulatory discussions over the potential overlap of the EU’s AI regulation with the MDR and IVDR.
But equally important is the question of demonstrating the value of AI in medtech so that payers will reimburse products that are based on such technology
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?